Research on the Diagnosis and Treatment of Angle Closure Glaucoma With Abnormal Lens Zonular
NCT ID: NCT05163093
Last Updated: 2023-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2020-11-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Corneal Astigmatism Before Glaucoma Surgery in Chinese Patients With Primary Angle-closure Glaucoma
NCT03159780
Correlation Between Angle Closure Glaucoma Data and Lens Zonule Status
NCT06184620
Implantation of Capsular Tension Ring in Primary Angle Closure Patients With Zonular Laxity or Dialysis
NCT05542290
Anterior Segment Anatomic Parameters for Risk Profiling of Primary Angle-closure Glaucoma
NCT06143943
Biometry of Occult Lens Subluxation Misdiagnosed as Primary Acute Angle Closed Glaucoma
NCT03752710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
(1)age: 45-79 years old, BCVA\>0.3, 19mm\<axial length\<24mm. (2).Continuous cases diagnose with angle-closure glaucoma in Beijing Tongren Hospital from January 1st, 2022 to December 31th, 2023 and undergo phacoemulsification lens extraction combined with intraocular lens implantation combined with anterior chamber angle separation will be included in the case group. (3). The patients who are diagnosed age-related cataract and undergo phacoemulsification lens extraction combined with intraocular lens implantation at the same time in Beijing Tongren Hospital will be included as control group. (4). All the surgeries were finished by the same two experienced ophthalmologists. (5). Both eyes will be undergo with surgery, and we will include the first eye for observation.
2.Exclusion critieria:
(1)Age-related cataract patients whose anterior chamber depth (ACD)\<2.5mm, 22mm\>axial length, or axial length\>26mm. (2).Patients who underwent ocular surgery, such as peripheral iridotomy, trabeculectomy. (3). Patients with history of ocular trauma. (4).Patients with other ophthalmic diseases that can cause shallow anterior chamber expect glaucoma and cataract, such as choroid detachment, ciliary body detachment, retinal detachment, bulbar tumor, etc. (5). Secondary glaucoma, such as neovascular glaucoma.
3.Diagnostic critieria:
1. angle-closure glaucoma (ACG): a. Both eyes with shallow anterior chamber (ACD\<2.5mm). b. With short axial length (axial length\<24mm).
2. acute angle-closure glaucoma (AACG): a. Both eyes with ACG characteristic anatomical structure, including shallow anterior chamber and short axial length. b.Patients with classic history of acute episode, acute elevated intraocular pressure, and atrioscopy or ultrasound biomicroscope (UBM) examination indicated angle closure. c. Ocular examination showed the characteristic changes of acute ocular hypertension: iris atrophy, dilated pupil, glaucoma spot, and pigmented Kp.
4\. Diagnostic criteria for lens suspensory ligament abnormalities
1. . Pre-operation: a. UBM shows the distance from ciliary processes to the equatorial part of lens varies in different directions. b. ACD are different between the two eyes and/or lens iris septum tremors by slit-lamp examination.
2. .Intraoperation: a. Suspensory ligament relaxation: with obvious radial folds on lens anterior capsules during continuous circular capsulorhexis (CCC), and could not observe the equator of lens. b. Rupture of suspensory ligament: could observe the equator of lens after full dilation of the pupil.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Angle closure glaucoma patients with or without abnormal zonular.
We observe the zonular during surgery, and divide patients into two groups according to their zonular, including with or without abnormal zonular.
No interventions assigned to this group
Patients with age-related cataract.
We observe the zonular during surgery, and divide patients into two groups according to their zonular, including with or without abnormal zonular.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Clinical diagnosis of angle-closure glaucoma, with 19mm\<axial length\<24mm.
3. Clinical diagnosis of age-related cataract (as control group), with 22mm\<axial length\<26mm.
4. All the surgeries were finished by the same two experienced ophthalmologists.
5. The first operated eye was included for observation.
Exclusion Criteria
2. Patients who underwent ocular surgery, such as peripheral iridotomy, trabeculectomy.
3. Patients with history of ocular trauma.
4. Patients with other ophthalmic diseases that can cause shallow anterior chamber expect glaucoma and cataract, such as choroid detachment, ciliary body detachment, retinal detachment, bulbar tumor, etc.
5. Secondary glaucoma, such as neovascular glaucoma.
45 Years
79 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chunyan Qiao_2021
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chunyan Qiao_2021
Ophthalmologist, Chief of out-patient department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beijing Tongren Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Angle closure glaucoma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.